Lineage Revenue Per Share from 2010 to 2024

LCTX Stock  USD 0.57  0.04  6.56%   
Lineage Cell Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 0.03 in 2024. Revenue Per Share is the amount of revenue generated by Lineage Cell Therapeutics per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
0.05180612
Current Value
0.0298
Quarterly Volatility
0.02597701
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lineage Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lineage Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 922.5 K, Interest Expense of 6 M or Total Revenue of 9.4 M, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0015 or PTB Ratio of 3.12. Lineage financial statements analysis is a perfect complement when working with Lineage Cell Valuation or Volatility modules.
  
Check out the analysis of Lineage Cell Correlation against competitors.

Latest Lineage Cell's Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of Lineage Cell Therapeutics over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Lineage Cell's Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lineage Cell's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.03410 Years Trend
Pretty Stable
   Revenue Per Share   
       Timeline  

Lineage Revenue Per Share Regression Statistics

Arithmetic Mean0.03
Geometric Mean0.03
Coefficient Of Variation74.41
Mean Deviation0.02
Median0.03
Standard Deviation0.03
Sample Variance0.0007
Range0.0874
R-Value(0.12)
Mean Square Error0.0007
R-Squared0.01
Significance0.66
Slope(0.0007)
Total Sum of Squares0.01

Lineage Revenue Per Share History

2024 0.0298
2023 0.0518
2022 0.0866
2021 0.0237
2020 0.005152
2019 0.0102
2018 0.0112

About Lineage Cell Financial Statements

Lineage Cell investors use historical fundamental indicators, such as Lineage Cell's Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lineage Cell. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 0.05  0.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lineage Stock Analysis

When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.